Latest stories on DCOY
Decoy Therapeutics’ D-MAV Platform Shows Breakthrough Activity Against Ebola Zaire—Advancing Multi-Viral Pandemic Defense
July 27, 2026
MarketChameleon73 · bullishproduct/pr
DCOY’s D-MAV Platform Shows Breakthrough Activity Against Ebola and Lassa Fever—What Could It Mean for Global Health Preparedness?
July 27, 2026
MarketChameleon67 · bullishproduct/pr
Decoy Therapeutics Inc. (DCOY) files 8-K
SEC 8-K50 · neutralgeneral
Why Is Penny Stock Decoy Therapeutics (DCOY) Up Today?
TipRanks52 · neutralgeneral
DCOY Stock Nearly Doubled In Value Today – What’s Driving This Mega Rally?
Stocktwits News73 · bullishgeneral
DCOY’s $21 Million Private Placement Marks Major Step for Multi-Virus Drug Development
MarketChameleon56 · neutralgeneral
Decoy Therapeutics secures $3.5M PIPE financing; shares surge
Seeking Alpha58 · neutralgeneral
Milestone-Driven $21M Financing Gives Decoy Therapeutics Room to Advance Clinical Programs
MarketChameleon54 · neutralgeneral
Decoy Therapeutics Inc. (DCOY) files 8-K
SEC 8-K50 · neutralgeneral
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing | DCOY Stock News
StockTitan24 · bearishgeneral
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
PR Newswire24 · bearishgeneral
Decoy Therapeutics' CEO to Participate in hVIVO Capital Markets Day in London | DCOY Stock News
StockTitan56 · neutralproduct/pr
Decoy Therapeutics Nominates Global Biopharma Executive Patricia Gauthier for Election to Board of Directors
PR Newswire56 · neutralgeneral
hVIVO wins Decoy Therapeutics consultancy mandate for next-generation respiratory antivirals
TipRanks63 · neutralproduct/pr
Decoy Therapeutics Partners with hVIVO to Advance Lead D-MAV™ Candidate into the Clinic
PR Newswire63 · neutralproduct/pr
Decoy Therapeutics Sets 2026 Annual Shareholder Meeting Date
TipRanks50 · neutralgeneral